ASH 2024 Summary: MPN Highlights and Clinical Implications

2024 ASH Annual Meeting Insights Hub

D. Tremblay

Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Thrombosis in Patients With ITP

Platelet Disorder Support Association (PDSA)

H. Liebman

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

ASH 2024 Review: New Therapies in ITP

Cleveland Clinic Taussig Cancer Institute

A. Hubben

Pulmonary Embolism: Role of Catheter-Based Interventions

Baylor College of Medicine

P. Loyalka

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

Diagnosis of Thalassemia: Molecular, Lab-Based, and Iron-Based Testi…

Sean Campbell

Monitoring Guidelines for Thalassemia Syndromes

Farrukh Shah

Misinformation in ITP

Platelet Disorder Support Association (PDSA)

D. Nugent

Initial Approach and Considerations for Management of ITP

Nicoletta Machin

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Principles of Iron Management in Thalassemia

Nita Radhakrishnan

Management of Treatment-Naive ITP Patients

Weill Cornell Medicine Oncology & Hematology

J. Bussel

ASH 2025 Review: Heavy Menstrual Bleeding and Iron Deficiency in Wom…

University of Colorado Division of Hematology

T. Buckner

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler